RKDA Arcadia Biosciences

Freedom Leaf, Inc. CEO Clifford J. Perry Returns to Uptick Newswire with Marcus Heatherly

Freedom Leaf, Inc. CEO Clifford J. Perry Returns to Uptick Newswire with Marcus Heatherly

LAS VEGAS, June 27, 2018 (GLOBE NEWSWIRE) -- Freedom Leaf, Inc. (OTCQB:FRLF), a group of international vertically integrated hemp businesses focused on health, wellness, education and media products, today announced CEO Clifford J. Perry returned to Uptick Newswire for a recap of the many successes the Company has recently achieved.

“I know you are doing a lot of work in Europe lately,” said Heatherly.  “Can you tell us about the inspiration behind entering that market?”

“We always believed there would be a major strategic play for the emerging cannabis and hemp sector in Europe,” said Perry. “Our team has done an incredible job finding us properties and acquisitions. Our first acquisition was LaMarihuana.com, one of the largest Spanish-speaking cannabis and hemp websites.”

LaMarihuana.com has 1.7 million visitors a month, adding significant media coverage internationally.  Additionally, after recent transactions Freedom Leaf will be the largest indoor hemp cultivation facility in the world.

“We are building products and services in the health and wellness sector that can be trusted,” said Perry.  

About Freedom Leaf, Inc.®

is a group of diversified, international, vertically-integrated hemp businesses concentrating on health, wellness, and education as well as cannabis media companies. Freedom Leaf Inc. is a fully-reporting and audited publicly-traded company under the symbol (OTCQB:FRLF). Freedom Leaf Inc. has been a leading go-to resource in the cannabis, medical marijuana and industrial hemp industries since 2014, founded by professionals with over 200 years combined experience in marijuana legalization advocacy. FRLF is building a diverse portfolio of valuable businesses through strategic mergers, acquisitions, and acceleration projects across the industry.

FRLF’s large portfolio of acquisitions and properties includes: our recently acquired full spectrum hemp oil product line - ; our wholly-owned hemp extraction division - ; our exclusive health and wellness full spectrum hemp oil brand - , our just-acquired indoor hemp greenhouse in Valencia, Spain for the cultivation of Hemp; our hemp-based rolling paper company - ; two of the largest Spanish-speaking cannabis web portals in the world - and , and of course our flagship publication - .

Utilizing these mergers and acquisitions, Freedom Leaf Inc. is continually building a solid foundation for our vertically-integrated hemp company to maximize both revenue growth, and net profit, which will increase our shareholders value. Our cultivation and extraction divisions allow FRLF to grow and source our own hemp CBD, which allows dramatically lower production costs for our wholly-owned CBD product lines, thereby generating more revenue for each product sold. We formulate and manufacture the majority of our products in our own in-house formulation centers, also greatly reducing our costs and increasing revenue. In addition, our extensive domestic and international media companies ensure we can continuously direct traffic to our many ecommerce sites and nationwide retail locations.

Freedom Leaf Inc. also sells licenses to use the Freedom Leaf brand in different countries and states across the globe. We have entered into three license agreements: for Spain and Portugal, for The Netherlands, and for Southern California.

Freedom Leaf, Inc. does not handle, grow, sell, or dispense marijuana or related products

All of our European activities are in full compliance with relevant EU laws.

Investor relations information can be found on the  company website.

Safe Harbor Statement

This news release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be covered by the “safe harbor” created by those sections. Forward-looking statements, which are based on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as “believe,” “expect,” “may,” “will,” “should,” “could,” “seek,” “intend,” “plan,” “goal,” “estimate,” “anticipate” or other comparable terms. All statements other than statements of historical facts included in this news release regarding our strategies, prospects, financial condition, operations, costs, plans and objectives are forward-looking statements. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: our ability to successfully market our products and services; the acceptance of our products and services by customers; our continued ability to pay operating costs and ability to meet demand for our products and services; the amount and nature of competition from other media and cannabis/hemp-related products and services; the effects of changes in laws governing the cannabis and hemp industries; our ability to successfully develop and sell new products and services; our success establishing and maintaining industry relationships, licensing and supplier arrangements; our ability to comply with applicable regulations; and the other risks and uncertainties described in our prior filings with the Securities and Exchange Commission. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

Contact:

Raymond Medeiros

PR and Business Development Director

Phone: 415-601-1974

Freedom Leaf, Inc.

 is a proud sponsor of Stock Day and Uptick Newswire encourages listeners to visit Freedom Leaf Inc., message board on:  



Source:

EN
27/06/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Arcadia Biosciences

Arcadia Biosciences Inc: 1 director

A director at Arcadia Biosciences Inc maiden bought 5,000 shares at 4.310USD and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last tw...

 PRESS RELEASE

Freedom Leaf, Inc. CEO Clifford J. Perry Returns to Uptick Newswire wi...

Freedom Leaf, Inc. CEO Clifford J. Perry Returns to Uptick Newswire with Marcus Heatherly LAS VEGAS, June 27, 2018 (GLOBE NEWSWIRE) -- Freedom Leaf, Inc. (OTCQB:FRLF), a group of international vertically integrated hemp businesses focused on health, wellness, education and media products, today announced CEO Clifford J. Perry returned to Uptick Newswire for a recap of the many successes the Company has recently achieved. “I know you are doing a lot of work in Europe lately,” said Heatherly.  “Can you tell us about the inspiration behind entering that market?” “We always believed there w...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch